Effects of excitotoxic lesions of the basal forebrain on MFB self-stimulation.
Electrolytic lesions of the anterior medial forebrain bundle (MFB) have been shown to attenuate the rewarding impact of stimulating more caudal MFB sites. In the present study, excitotoxic lesions were employed to determine the relative contribution of somata or fibers of passage contributing to that effect. Changes in reward efficacy were inferred, at three currents, from lateral displacements of the curve relating the rate of responding to the number of stimulation pulses per train. After baseline data were collected from stimulation sites in the lateral hypothalamus (LH) and the ventral tegmental area (VTA), 70 nmol of N-methyl-D-aspartic acid was injected via cannulae aimed at basal forebrain sites. Three subjects were injected with vehicle and served as controls. In 5 out of 15 cases, lesions encompassing the lateral preoptic area, anterior LH, and substantia innominata resulted in long-lasting, large increases (0.2-0.47 log10 units) in the number of pulses required to maintain half-maximal rates of self-stimulation for low currents delivered via the LH electrode; smaller increases (0.08-0.33 log10 units) were noted at moderate and high currents. Seven rats with similar or more dorsally located damage showed moderate or transient increases in the number of pulses required to maintain half-maximal rates of LH or VTA self-stimulation. Vehicle injections did not affect behaviour. Varying degrees of demyelination were seen, mostly removed from the electrode tip, and in locations that varied substantially across subjects manifesting similar changes in self-stimulation. These results support the notion that somata in the basal forebrain give rise to some of the directly activated fibers subserving self-stimulation of the MFB.
Arvanitogiannis
A
A
Department of Psychology, Concordia University, Montréal, Qué., Canada.
Waraczynski
M
M
Shizgal
P
P
D000818:Animals; D001369:Axons / Q000502:physiology; D003216:Conditioning, Operant / Q000502:physiology; D018690:Excitatory Amino Acid Agonists / Q000008:administration & dosage / Q000633:toxicity*; D007026:Hypothalamic Area, Lateral / Q000033:anatomy & histology / Q000502:physiology; D007267:Injections; D008297:Male; D008474:Medial Forebrain Bundle / Q000033:anatomy & histology / Q000502:physiology*; D016202:N-Methylaspartate / Q000008:administration & dosage / Q000633:toxicity*; D011301:Preoptic Area; D016548:Prosencephalon / Q000033:anatomy & histology / Q000502:physiology*; D051381:Rats; D012201:Reward; D012653:Self Stimulation / Q000502:physiology*; D017557:Ventral Tegmental Area / Q000033:anatomy & histology / Q000502:physiology
D018690:Excitatory Amino Acid Agonists; D016202:N-Methylaspartate